These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10942954)

  • 1. Oral anticoagulants and cyclosporin A.
    Turri D; Iannitto E; Caracciolo C; Mariani G
    Haematologica; 2000 Aug; 85(8):893-4. PubMed ID: 10942954
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased INR response secondary to warfarin-flucloxacillin interaction.
    Garg A; Mohammed M
    Ann Pharmacother; 2009 Jul; 43(7):1374-5. PubMed ID: 19584391
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to rebuttal: Gene variants of the cytochrome P450 CYP2C9 affect oral anticoagulation with warfarin.
    Margaglione M; Brancaccio V; Ciampa A; Di Minno G
    Thromb Haemost; 2001 Sep; 86(3):938. PubMed ID: 11583336
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral anticoagulation with warfarin is significantly influenced by steroids and CYP2C9 polymorphisms in children with cancer.
    Ruud E; Holmstrøm H; Bergan S; Wesenberg F
    Pediatr Blood Cancer; 2008 Mar; 50(3):710-3. PubMed ID: 17226852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin resistance with poor CYP2C9 activity and CYP2C9*1*2 genotype.
    Dericioglu N; Babaoglu MO; Saygi S; Bozkurt A; Yasar U
    Ann Pharmacother; 2004 May; 38(5):899. PubMed ID: 15039471
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) in a patient on warfarin therapy.
    Herman D; Peternel P; Stegnar M; Breskvar K; Dolzan V
    Thromb Haemost; 2006 Jan; 95(1):192-4. PubMed ID: 16543980
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulant therapy for venous thromboembolism.
    Raskob GE; Carter CJ; Hull RD
    Prog Hemost Thromb; 1989; 9():1-27. PubMed ID: 2643814
    [No Abstract]   [Full Text] [Related]  

  • 8. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin.
    Aki Z; Kotiloğlu G; Ozyilkan O
    Am J Gastroenterol; 2000 Apr; 95(4):1093-4. PubMed ID: 10763974
    [No Abstract]   [Full Text] [Related]  

  • 9. [Terbinafine and warfarin interaction].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 1999 May; 126(5):463. PubMed ID: 10434116
    [No Abstract]   [Full Text] [Related]  

  • 10. Increase in anticoagulant effect of warfarin in a patient using econazole cream.
    Lang PG; LeClercq AH
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S117-9. PubMed ID: 17052529
    [No Abstract]   [Full Text] [Related]  

  • 11. Warfarin resistance in a patient with short bowel syndrome.
    Brophy DF; Ford SL; Crouch MA
    Pharmacotherapy; 1998; 18(3):646-9. PubMed ID: 9620117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in international normalized ratio after smoking cessation in a patient receiving warfarin.
    Evans M; Lewis GM
    Pharmacotherapy; 2005 Nov; 25(11):1656-9. PubMed ID: 16232028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant therapy: through a glass darkly.
    Hampton JW
    Am Fam Physician; 1974 Feb; 9(2):100-4. PubMed ID: 4810867
    [No Abstract]   [Full Text] [Related]  

  • 14. INR elevation with maitake extract in combination with warfarin.
    Hanselin MR; Vande Griend JP; Linnebur SA
    Ann Pharmacother; 2010 Jan; 44(1):223-4. PubMed ID: 20040699
    [No Abstract]   [Full Text] [Related]  

  • 15. Warfarin sensitivity and genetic polymorphisms: should pharmacokinetic screening be part of anticoagulant dosing decisions?
    Baglin TP
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):656-7. PubMed ID: 16258463
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous warfarin as an alternative for anticoagulation.
    Gellatly RM
    Pharmacotherapy; 2007 Jun; 27(6):933-5. PubMed ID: 17542775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible warfarin failure due to interaction with smokeless tobacco.
    Kuykendall JR; Houle MD; Rhodes RS
    Ann Pharmacother; 2004 Apr; 38(4):595-7. PubMed ID: 14766993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interaction between warfarin and oral miconazole gel].
    Ogard CG; Vestergaard H
    Ugeskr Laeger; 2000 Oct; 162(41):5511. PubMed ID: 11068529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin and extractions.
    Gibbons AJ; Evans IL; Sayers MS; Price G; Snooks H; Sugar AW
    Br Dent J; 2002 Sep; 193(6):302. PubMed ID: 12368872
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose.
    Herman D; Locatelli I; Grabnar I; Peternel P; Stegnar M; Mrhar A; Breskvar K; Dolzan V
    Pharmacogenomics J; 2005; 5(3):193-202. PubMed ID: 15824753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.